Want to see SNDL full AI Analyst Report?
SNDL Stock Chart & Stats
$1.35
>-$0.01(-0.40%)
At close: 4:00 PM EDT
$1.35
>-$0.01(-0.40%)
Day’s Range― - ―
52-Week Range$1.17 - $2.89
Previous CloseN/A
Volume1.71M
Average Volume (3M)1.27M
Market Cap
$344.57M
Enterprise Value$320.28
Total Cash (Recent Filing)$186.57M
Total Debt (Recent Filing)$166.38M
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Nov 10, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding246,120,850
10 Day Avg. Volume1,340,391
30 Day Avg. Volume1,269,407
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)0.53
Price to Sales (P/S)0.62
P/FCF Ratio10.12
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$3.50Price Target Upside159.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.02
Revenue Forecast (FY)$921.96M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage gives SNDL financial flexibility to fund operations, pursue strategic investments, and absorb industry volatility without excessive refinancing pressure. This balance-sheet resilience is durable because it reduces dependence on debt markets while the company works toward consistent profitability.
U.S. Medical Cannabis ExpansionThe Parallel asset deal broadens SNDL from a primarily Canadian platform into U.S. medical cannabis, adding retail and production infrastructure in three states. Subject to required approvals and control changes, this creates a larger operating base and meaningful long-term growth optionality.
International Medical Cannabis CapabilityEU-GMP certification strengthens SNDL’s ability to participate in regulated international medical cannabis markets, where compliance and production quality are important barriers to entry. Atholville’s existing scale and potential capacity expansion could support a more durable export platform.
Bears Say
Persistent Revenue ContractionRevenue contraction indicates that SNDL has not yet established durable top-line momentum across its operating segments. Shrinking sales can limit fixed-cost absorption, reduce reinvestment capacity, and make management’s planned profitability improvements harder to sustain over the next several quarters.
Severe Cannabis Operations Margin PressureA 1.8% gross margin leaves little room to cover operating expenses and exposes the cannabis division to further earnings volatility. Management expects Jeeter ramp inefficiencies to persist in coming months, so recovery depends on executing production improvements rather than benefiting from a temporary cost reversal.
Liquor Retail WeaknessDeclining same-store sales and gross profit show pressure in a major recurring retail activity, while increased promotions are reducing margin quality. If weaker volumes and promotional intensity continue, liquor retail may contribute less operating income and offset gains from other growth initiatives.
SNDL News
SNDL FAQ
What was SNDL’s price range in the past 12 months?
SNDL lowest stock price was $1.17 and its highest was $2.89 in the past 12 months.
What is SNDL’s market cap?
SNDL’s market cap is $344.57M.
When is SNDL’s upcoming earnings report date?
SNDL’s upcoming earnings report date is Nov 10, 2026 which is in 45 days.
How were SNDL’s earnings last quarter?
SNDL released its earnings results on Jul 28, 2026. The company reported -$0.022 earnings per share for the quarter, missing the consensus estimate of -$0.004 by -$0.018.
Is SNDL overvalued?
According to Wall Street analysts SNDL’s price is currently Undervalued.
Does SNDL pay dividends?
SNDL does not currently pay dividends.
What is SNDL’s EPS estimate?
SNDL’s EPS estimate is -0.01.
How many shares outstanding does SNDL have?
SNDL has 246,120,850 shares outstanding.
What happened to SNDL’s price movement after its last earnings report?
SNDL reported an EPS of -$0.022 in its last earnings report, missing expectations of -$0.004. Following the earnings report the stock price went down -9.63%.
Which hedge fund is a major shareholder of SNDL?
Currently, no hedge funds are holding shares in SNDL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SNDL Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.50 (159.26% Upside)
$3.50 (159.26% Upside)
Blogger Sentiment
Bullish
SNDL Sentiment 75%
Sector Average 64%
Sector Average 64%
Hedge Fund Trend
Decreased
By 18.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $52.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.08%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
SNDL
SNDL Inc. is a Canadian firm engaged in the cultivation, distribution, and sale of cannabis products across the country. Its operations are organized into two distinct segments: Cannabis Operations and Retail Operations. Through its Cannabis Operations, the company manages the growing, supplying, and selling of cannabis specifically for the adult-use market. Meanwhile, its Retail Operations segment is responsible for the direct private sale of recreational cannabis via a network of both corporate-owned and franchised retail outlets. SNDL also produces and distributes a range of inhalable cannabis products, including dried flower, pre-rolled joints, and vape cartridges. These items are marketed under several key brands, such as Top Leaf, Sundial Cannabis, Palmetto, and Grasslands. The company, originally incorporated in 2006 as Sundial Growers Inc., officially adopted its current name, SNDL Inc., in July 2022. Its main corporate office is situated in Calgary, Canada.
SNDL Company Deck
SNDL Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The quarter presented a mixed picture: operational performance was challenged with declines in revenue, gross profit and segment-level profitability (notably in cannabis operations and liquor retail), driven by market softness and production ramp inefficiencies (Jeeter). Offsetting these headwinds, SNDL entered transformational capital and strategic positions — strong liquidity (CAD 183.2M), zero debt, accelerated share repurchases (~7% reduction in shares outstanding), deployment of profit enhancement initiatives (>CAD 20M expected), modest improvement in free cash flow, and the completion of a major parallel restructuring milestone that opens access to a sizeable U.S. medical cannabis platform with material upside. Given substantial near-term operational challenges balanced against meaningful balance sheet strength and strategic optionality, the call’s tone is cautiously constructive but mixed.View all SNDL earnings summariesSNDL Stock 12 Month Forecast
Average Price Target
$3.50
▲(159.26% Upside)
Technical Analysis
Ownership Overview
2.54% Insiders
0.22% Mutual Funds
5.28% Other Institutional Investors
88.68% Public Companies and
Individual Investors